$46.25
0.67% day before yesterday
NYSE, Nov 21, 10:13 pm CET
ISIN
US1101221083
Symbol
BMY

Bristol-Myers Squibb Stock price

$46.25
+1.71 3.84% 1M
-0.75 1.60% 6M
-10.31 18.23% YTD
-11.98 20.57% 1Y
-32.71 41.43% 3Y
-15.67 25.31% 5Y
-21.74 31.98% 10Y
+23.96 107.49% 20Y
NYSE, Closing price Fri, Nov 21 2025
+0.31 0.67%

New AI Insights on Bristol-Myers Squibb Insights AI Insights on Bristol-Myers Squibb

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Key metrics

Basic
Market capitalization
$94.2b
Enterprise Value
$126.6b
Net debt
$32.5b
Cash
$16.5b
Shares outstanding
2.0b
Valuation (TTM | estimate)
P/E
15.6 | 7.1
P/S
2.0 | 2.0
EV/Sales
2.6 | 2.6
EV/FCF
8.3
P/B
5.1
Dividends
DPS
$2.42
Yield 1Y | 5Y
5.2% | 3.5%
Growth 1Y | 5Y
4.8% | 7.6%
Payout 1Y | 3Y
-54.9% | 288.3%
Increased
18 Years
Financials (TTM | estimate)
Revenue
$48.0b | $48.2b
EBITDA
$20.3b | $17.5b
EBIT
$16.1b | $16.1b
Net Income
$6.0b | $13.3b
Free Cash Flow
$15.3b
Growth (TTM | estimate)
Revenue
1.3% | -0.3%
EBITDA
-1.5% | -14.1%
EBIT
44.7% | 39.4%
Net Income
183.2% | 248.5%
Free Cash Flow
10.9%
Margin (TTM | estimate)
Gross
73.2%
EBITDA
42.2% | 36.4%
EBIT
33.5%
Net
12.6% | 27.6%
Free Cash Flow
31.9%
Financial Health
Equity Ratio
17.6%
Return on Equity
-54.8%
ROCE
23.4%
ROIC
16.9%
Debt/Equity
2.6
More
EPS
$3.0
FCF per Share
$7.5
Short interest
1.6%
Employees
34k
Rev per Employee
$1.4m
Show more

Is Bristol-Myers Squibb a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.

Bristol-Myers Squibb Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Bristol-Myers Squibb forecast:

11x Buy
33%
20x Hold
61%
2x Sell
6%

Analyst Opinions

33 Analysts have issued a Bristol-Myers Squibb forecast:

Buy
33%
Hold
61%
Sell
6%

Financial data from Bristol-Myers Squibb

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
48,034 48,034
1% 1%
100%
- Direct Costs 12,898 12,898
13% 13%
27%
35,136 35,136
2% 2%
73%
- Selling and Administrative Expenses 7,167 7,167
10% 10%
15%
- Research and Development Expense 9,719 9,719
3% 3%
20%
20,280 20,280
1% 1%
42%
- Depreciation and Amortization 4,184 4,184
56% 56%
9%
EBIT (Operating Income) EBIT 16,096 16,096
45% 45%
34%
Net Profit 6,039 6,039
183% 183%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Bristol-Myers Squibb directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bristol-Myers Squibb Stock News

Negative
Seeking Alpha
2 days ago
Bristol-Myers Squibb (BMY) faces a severe patent cliff, risking up to 60% of recent revenues as key blockbusters lose exclusivity. BMY's pipeline and recent acquisitions are unlikely to offset revenue declines, with new therapies facing intense competition and limited blockbuster potential. Financial fundamentals are deteriorating, with falling revenue, EBITDA margins, and net income, while hig...
Negative
Reuters
3 days ago
Texas Attorney General Ken Paxton sued Bristol Myers Squibb and Sanofi , accusing the drugmakers of failing to disclose that Plavix, which is used to prevent blood clots, does not work effectively for many patients.
Positive
Seeking Alpha
3 days ago
Screening large-cap Health Care names using earnings yield plus ROTC identified five undervalued blue-chip stocks over $100B market cap. Merck, Bristol-Myers, Gilead, Pfizer, and Amgen screen as the cheapest quality names using a Magic-Formula-style scoring method.
More Bristol-Myers Squibb News

Company Profile

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Head office United States
CEO Christopher Boerner
Employees 34,100
Founded 1933
Website www.bms.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today